Prospective analysis of radiation-induced contrast enhancement (RICE) and health-related quality of life following proton therapy for CNS and skull base tumors
Carola Lütgendorf-Caucig,Maciej Pelak,Eugen Hug,Birgit Flechl,Birgit Surböck,Christine Marosi,Ulrike Mock,Leor Zach,Yael Mardor,Orit Furman,Harald Hentschel,Joanna Gora,Piero Fossati,Markus Stock,Uwe Graichen,Sascha Klee,Petra Georg,Dr. Med. Carola Lütgendorf-Caucig,Dr. med. Maciej Pelak,Prof. Dr. Eugen Hug,Dr. Med. Ing. Birgit Flechl,Dr. Med. Birgit Surböck,Prof. Dr. Med. Christine Marosi,Dr. Med. Ulrike Mock,Prof. Dr. Med. Yael Mardor,Prof. Dr. Med. Piero Fossati,Prof. Markus Stock,Prof. Dr. Ing. Sascha Klee,PD Dr. Med. Petra Georg
DOI: https://doi.org/10.1016/j.ijrobp.2024.01.007
IF: 8.013
2024-01-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:PURPOSE: Intracerebral radiation-induced contrast enhancement (RICE) can occur after photon as well as proton beam therapy (PBT). This study evaluated the incidence, characteristics, and risk factors of RICE after PBT delivered to, or in direct proximity to, the brain and its effect on health-related quality of life (HRQoL).METHODS AND MATERIALS: Four hundred twenty-one patients treated with pencil beam scanning PBT between 2017 and 2021 were included. Follow-up included clinical evaluation and contrast-enhanced magnetic resonance imaging at 3, 6, and 12 months after treatment completion and annually thereafter. RICE was graded according to Common Terminology Criteria for Adverse Events version 4, and HRQoL parameters were assessed via European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 questionnaires.RESULTS: The median follow-up was 24 months (range, 6-54), and median dose to 1% relative volume of noninvolved central nervous system (D1%CNS) was 54.3 Gy relative biologic effectiveness (RBE; range, 30-76 Gy RBE). The cumulative RICE incidence was 15% (n = 63), of which 10.5% (n = 44) were grade 1, 3.1% (n = 13) were grade 2, and 1.4% (n = 6) were grade 3. No grade 4 or 5 events were observed. Twenty-six of 63 RICE (41.3%) had resolved at the latest follow-up. The median onset after PBT and duration of RICE in patients in whom the lesions resolved were 11.8 and 9.0 months, respectively. On multivariable analysis, D1%CNS > 57.6 Gy RBE, previous in-field radiation, and diabetes mellitus were identified as significant risk factors for RICE development. Previous radiation was the only factor influencing the risk of symptomatic RICE. After PBT, general HRQoL parameters were not compromised. In a matched cohort analysis of 54/50 patients with and without RICE, no differences in global health score or functional and symptom scales were seen.CONCLUSIONS: The overall incidence of clinically relevant RICE after PBT is very low and has no significant negative effect on long-term patient QoL.
oncology,radiology, nuclear medicine & medical imaging